Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ampel Biosolutions
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ampel Biosolutions

Ampel Biosolutions

Seed

US-based precision medicine firm offering LDTs for disease prediction, molecular pathways, and drug options.

HQ
Charlottesville, VA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded in Charlottesville, United States, Ampel Biosolutions is a precision medicine company dedicated to revolutionizing the management of autoimmune and inflammatory diseases. Their core mission is to provide personalized, predictive care through advanced RNA analytics and AI-driven insights. Ampel offers Laboratory Developed Tests (LDTs) that predict disease status, identify molecular pathways, and suggest optimal drug options. Their market focus includes conditions such as lupus, dermatology issues, nephrology, fibromyalgia, cardiology, arthritis, and infections.

Notable figures affiliated with Ampel Biosolutions include a distinguished executive team and advisory group comprising experts in precision medicine and AI. The company has made significant strides in the healthcare sector by publishing influential research papers and forming strategic partnerships. Ampel's innovative approach has garnered attention for its potential to transform patient care and improve outcomes through tailored treatment strategies.

Ampel Biosolutions - Similar Companies

Amplified Sciences logo

Amplified Sciences

BioAmp diagnostics logo

BioAmp diagnostics

bioampdx.com

Ariel Precision Medicine logo

Ariel Precision Medicine

arielmedicine.com

Amprion logo

Amprion

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

HI-Bio logo

HI-Bio

hibio.com

Amplifica logo

Amplifica

amplificabio.com

Ampere Life Sciences logo

Ampere Life Sciences

bioSyntagma logo

bioSyntagma

biosyntagma.com

Path BioAnalytics logo

Path BioAnalytics

AMPLY Discovery logo

AMPLY Discovery

amplydiscovery.com

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

Aperture Bio logo

Aperture Bio

aperture.bio

Amplo Biotechnology logo

Amplo Biotechnology

Amydis logo

Amydis

amydis.com

Ampel Biosolutions - Quick Facts

Who are Ampel Biosolutions' competitors?

Companies similar to Ampel Biosolutions include Amplified Sciences, BioAmp diagnostics, Ariel Precision Medicine and Amprion.

When was Ampel Biosolutions founded?

Ampel Biosolutions was founded in 2013.

Where is Ampel Biosolutions' headquarters located?

Ampel Biosolutions' headquarters is located in Charlottesville, VA, US.

When was Ampel Biosolutions' last funding round?

Ampel Biosolutions' most recent funding round was for $1.8M (USD) in July 2023.

How much has Ampel Biosolutions raised to-date?

As of Jul 6, 2023, Ampel Biosolutions has raised a total of $14.3M (USD).

How many employees does Ampel Biosolutions have?

Ampel Biosolutions has 29 employees as of Feb 4, 2024.

Ampel Biosolutions - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Ldts
  • Precision Medicine
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified